Compound Summary
Oxyresveratrol
Compound Information
Oxyresveratrol
Compound Name: | Oxyresveratrol |
Compound CID: | 5281717 |
Synonyms: | Oxyresveratrol 29700-22-9 Hydroxyresveratrol Tetrahydroxystilbene trans-oxyresveratrol More... |
Iupac Name: | 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol |
InChI: | InChI=1S/C14H12O4/c15-11-4-3-10(14(18)8-11)2-1-9-5-12(16)7-13(17)6-9/h1-8,15-18H/b2-1+ |
InChIKey: | PDHAOJSHSJQANO-OWOJBTEDSA-N |
Canonical Smiles: | C1=CC(=C(C=C1O)O)C=CC2=CC(=CC(=C2)O)O |
Isomeric Smiles: | C1=CC(=C(C=C1O)O)/C=C/C2=CC(=CC(=C2)O)O |
Molecular Weight: | 244.24 |
Molecular Formula: | C14H12O4 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Oxyresveratrol
Molecular Weight: | 244.24 |
Molecular Formula: | C14H12O4 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 18 |
Complexity: | 282 |
Synonyms
Oxyresveratrol
| Oxyresveratrol | Oxyresveratrol |
|---|---|
Oxyresveratrol |
29700-22-9 |
Hydroxyresveratrol |
Tetrahydroxystilbene |
trans-oxyresveratrol |
(E)-4-(3,5-Dihydroxystyryl)benzene-1,3-diol |
4-(E)-2-(3,5-dihydroxyphenyl)ethenylbenzene-1,3-diol |
UNII-6V071CP5CR |
OXYLRESVERATROL |
4721-07-7 |
4-2-(3,5-dihydroxyphenyl)ethenylbenzene-1,3-diol |
2,3,4,5-Tetrahydroxystilbene |
1,3-Benzenediol, 4-(1E)-2-(3,5-dihydroxyphenyl)ethenyl- |
CHEMBL43065 |
6V071CP5CR |
CHEBI:7870 |
Puag-haad |
Oxyresveratrol A |
2,4,3,5-Tetrahydroxystilbene |
EZE |
O-RES cpd |
MLS002473086 |
SCHEMBL501690 |
3 4 5-tetrahydroxystilbene |
MEGxp0_001057 |
REGID_for_CID_658108 |
ACon1_001063 |
cid_5281717 |
4-(E)-2-(3,5-dihydroxyphenyl)vinylbenzene-1,3-diol |
REGID_for_CID_5281717 |
HMS2218H19 |
HMS3885N20 |
ZINC899161 |
1,3-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-, (E)- |
BCP24308 |
EBD28985 |
HY-N1430 |
BDBM50108046 |
LMPK13090011 |
MFCD11974969 |
NSC315550 |
s4739 |
Oxyresveratrol, >=97.0% (HPLC) |
AKOS015915071 |
AC-5279 |
CCG-266904 |
CS-5655 |
MCULE-6461324045 |
NSC 315550 |
NSC-315550 |
trans-2,3,4,5-Tetramethoxystilbene" |
trans-2,3,4,5-tetrahydroxystilbene" |
trans-2,4,3,5-tetrahydroxystilbene" |
2,3,4,5-Tetrahydroxy-trans-stilbene |
NCGC00169713-01 |
NCGC00169713-02 |
AS-35032 |
SMR001397189 |
trans-2,4,3,5-tetrahydroxystilbene |
4-(3,5-Dihydroxystyryl)benzene-1,3-diol |
AB0072945 |
N.357 |
O0373 |
700O229 |
A820013 |
J-501984 |
Q7116143 |
(E)-5,5-(ethene-1,2-diyl)bis(benzene-1,3-diol) |
1,3-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)- |
(oxyresveratrol)4-(E)-2-(3,5-dihydroxyphenyl)vinylbenzene-1,3-diol |
NCGC00169713-02!4-(E)-2-(3,5-dihydroxyphenyl)ethenylbenzene-1,3-diol |
Experimental Data
Oxyresveratrol
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 500.000000000000000 | umol/L | 13.500000000000000 | 15.900000000000000 | 0.180000000000000 | S | N2 | 27190265 | Active | ||||
| Caenorhabditis elegans | 100.000000000000000 | umol/L | 13.500000000000000 | 14.500000000000000 | 0.070000000000000 | S | N2 | 27190265 | Active | ||||
| Caenorhabditis elegans | 1000.000000000000000 | umol/L | 13.500000000000000 | 17.700000000000000 | 0.310000000000000 | S | N2 | 27190265 | Active |
Experimental Data Visualization
Oxyresveratrol
Statistics Data
Oxyresveratrol
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 0.310000000000000 | 1 | 3 |
Statistics Data Visualization
Oxyresveratrol
